Metis Global Partners, LLC Bio Rad Laboratories, Inc. Transaction History
Metis Global Partners, LLC
- $3.16 Billion
- Q3 2024
A detailed history of Metis Global Partners, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Metis Global Partners, LLC holds 682 shares of BIO stock, worth $232,241. This represents 0.01% of its overall portfolio holdings.
Number of Shares
682
Previous 1,028
33.66%
Holding current value
$232,241
Previous $280,000
18.57%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$650 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$528 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$444 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$370 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$243 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.39B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...